Gemcitabine in advanced bladder cancer

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 7, 2001, Pages 11-14

  Von der Maase, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

A new regimen of gemcitabine and paclitaxel in previously treated patients with advanced transitional cell carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ADVANCED CANCER; BLADDER CANCER; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 0035007441     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.24369     Document Type: Review

References (26)

1. BJ Roth Chemotherapy for advanced bladder cancer Semin Oncol 5 1996 633 644
2. W Harker FJ Meyers FS Freiha Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study J Clin Oncol 3 1985 1463 1470
3. CN Sternberg A Yagoda HI Scher Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: Efficacy and patterns of response and relapse Cancer 64 1989 2448 2458
4. HI Scher R Bahnson S Cohen NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network Oncology 12 1998 225 271
5. JP Connor CA Olsson MC Benson Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: Cause for concern Urology 34 1989 353 356
6. I Tannock M Gospodarowicz J Connolly M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: The Princess Margaret Hospital experience J Urol 142 1989 289 292
7. M Igawa T Ohkuchi T Ueki Usefulness and limitations for methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer J Urol 144 1990 662 665
8. A Boutan-Laroze M Mahjoubi JP Droz M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience Eur J Cancer 27 1991 1690 1694
9. PM Dodd JA McCaffrey H Herr Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma J Clin Oncol 17 1999 2546 2552
10. CN Sternberg PH de Mulder J Schornagel Randomized phase III trial in advanced urothelial tract tumors of high dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC Proc Am Soc Clin Oncol 19 2000 329a (abstr 1292)
11. PJ Loehrer Sr LH Einhorn PJ Elson A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A Cooperative Group study J Clin Oncol 10 1992 1066 1073
12. CJ Logothetis FH Dexeus L Finn A prospective randomized trial comparing M-VAC and CISCA chemotherapy for patients with metastatic urothelial tumors J Clin Oncol 8 1990 1050 1055
13. SB Saxman KJ Propert LH Einhorn Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A Cooperative Group study J Clin Oncol 15 1997 2564 2569
14. CF Pollera A Ceribelli M Crecco Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I study Ann Oncol 5 1994 182 184
15. V Lorusso CF Pollera M Antimi A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Cooperative Group on Bladder Cancer Eur J Cancer 34 1998 1208 1212
16. WM Stadler T Kuzel B Roth Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer J Clin Oncol 15 1997 3394 3398
17. MJ Moore IF Tannock DS Ernst Gemcitabine: A promising new agent in the treatment of advanced urothelial cancer J Clin Oncol 15 1997 3441 3445
18. V Gebbia A Testa N Borsellino Single agent 2′,2′-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study Clin Ter 150 1999 11 15
19. H von der Maase L Andersen L Crinò Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial Ann Oncol 10 1999 1461 1465
20. D Kaufman D Raghavan M Carducci Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer J Clin Oncol 18 2000 1921 1927
21. JM Moore EW Winquist N Murray Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 17 1999 2876 2881
22. H von der Maase SW Hansen JT Roberts Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 2000 3068 3077
23. L Marini CN Sternberg A Sella A new regimen of gemcitabine and paclitaxel in previously treated patients with advanced transitional cell carcinoma Proc Am Soc Clin Oncol 18 1999 346a (abstr 1335)
24. AA Meluch FA Greco HA Burris Gemcitabine and paclitaxel in combination for advanced transitional cell carcinoma (TCC) of the urothelial tract: A trial of the Minnie Pearl Research Network Proc Am Soc Clin Oncol 18 1999 347a (abstr 1338)
25. J Bellmunt V Guillem JL Paz-Ares A phase I–II study of paclitaxel, cisplatin and gemcitabine in advanced transitional-cell carcinoma of the urothelium J Clin Oncol 18 2000 3247 3255
26. U Vaishampayan D Smith B Redman Phase II evaluation of carboplatin, paclitaxel and gemcitabine in advanced urothelial carcinoma Proc Am Soc Clin Oncol 18 1999 333a (abstr 1282)